93 related articles for article (PubMed ID: 21509803)
1. Pharmacological evaluation of halogenated and non-halogenated arylpiperazin-1-yl-ethyl-benzimidazoles as D(2) and 5-HT(2A) receptor ligands.
Tomić M; Vasković D; Tovilović G; Andrić D; Penjišević J; Kostić-Rajačić S
Arch Pharm (Weinheim); 2011 May; 344(5):287-91. PubMed ID: 21509803
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.
Tomić M; Kundaković M; Butorović B; Janać B; Andrić D; Roglić G; Ignjatović D; Kostić-Rajacić S
Bioorg Med Chem Lett; 2004 Aug; 14(16):4263-6. PubMed ID: 15261283
[TBL] [Abstract][Full Text] [Related]
4. Two new phenylpiperazines with atypical antipsychotic potential.
Tomić M; Ignjatović D; Tovilović G; Andrić D; Roglić G; Kostić-Rajacić S
Bioorg Med Chem Lett; 2007 Nov; 17(21):5749-53. PubMed ID: 17870534
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
6. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
[TBL] [Abstract][Full Text] [Related]
7. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
Gowri Chandra Sekhar KV; Rao VS; Deuther-Conrad W; Reddy AS; Brust P; Krishna Kumar MM
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):561-8. PubMed ID: 21171898
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary screening of novel N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as potential atypical antipsychotic agents.
Chandra Sekhar KV; Rao VS; Krishna MM
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):871-5. PubMed ID: 18825551
[TBL] [Abstract][Full Text] [Related]
14. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
16. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
17. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
Zajdel P; Marciniec K; Maślankiewicz A; Satała G; Duszyńska B; Bojarski AJ; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Pawłowski M
Bioorg Med Chem; 2012 Feb; 20(4):1545-56. PubMed ID: 22277589
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
[TBL] [Abstract][Full Text] [Related]
19. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
